Marc Koska

Co-Founder & Head of R&D at ApiJect

The inventor of ApiJect’s breakthrough BFS injection device is Marc Koska, one of the world’s most respected and successful social entrepreneurs.

In the mid-1980s, Mr. Koska invented the K-1 Auto-Disable Syringe, a device that stops the spread of blood-borne diseases and infection by making it impossible to reuse medical needles and syringes. In 2005, he founded the nonprofit SafePoint Trust to educate children about the dangers of employing used needles.

To date, Marc’s invention and leadership are estimated to have saved 12 million lives. In 2015, WHO director, Dr. Margaret Chan announced a new global policy on injection safety, promoting Auto-Disable syringes. The K-1 is now licensed and manufactured by 14 global manufacturers. Among many other honors bestowed upon Mr. Koska, he was made an Officer of the Order of the British Empire for his “contribution to global healthcare.”

Location

Enfield, United Kingdom

Links


Org chart


Teams


Offices

This person is not in any offices


ApiJect

2 followers

ApiJect Systems, Corp. is reimagining how injectable medicines can be packaged and delivered to the world. ApiJect’s technology platform is based on a design philosophy of basic interlocking components to create simple and highly-scalable drug delivery devices.


Industries

Employees

51-200

Links